| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
4.17(B) |
| Last
Volume: |
167,042 |
Avg
Vol: |
192,874 |
| 52
Week Range: |
$81.08 - $179.51 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
28,552 |
43,391 |
1,777,103 |
1,846,911 |
| Total Sell Value |
$4,537,816 |
$6,083,875 |
$189,906,340 |
$202,407,865 |
| Total People Sold |
3 |
6 |
9 |
9 |
| Total Sell Transactions |
4 |
7 |
20 |
28 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,296 |
19,207 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
D |
$161.25 |
$873,975 |
D/D |
(5,420) |
10,353 |
|
- |
|
| Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,296 |
14,957 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-06 |
4 |
D |
$161.25 |
$998,783 |
D/D |
(6,194) |
21,042 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,767 |
26,303 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-06 |
4 |
D |
$161.25 |
$100,943 |
D/D |
(626) |
9,943 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,417 |
10,569 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2023-02-02 |
4 |
AS |
$200.00 |
$346,200 |
D/D |
(1,731) |
9,152 |
|
-2% |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2022-11-15 |
4 |
AS |
$160.12 |
$52,039 |
D/D |
(325) |
3,046 |
|
2% |
|
| Lopez George A |
Director |
– • – |
2022-09-21 |
4 |
OE |
$61.76 |
$4,914,614 |
D/D |
79,576 |
361,020 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2022-05-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
30 |
15,469 |
|
- |
|
111 Records found
|
|
Page 5 of 5 |
|
|
0.25 (0.14%) 
